title: Bedaquiline: Introducing a new drug to the MDR TB armamentarium.
authors.affiliation: Johnson & Johnson Global Public Health, 700 US Highway 202 South, Raritan, NJ 08869, USA. Electronic address: ckambili@its.jnj.com.
authors.forename: Chrispin
authors.initials: C
authors.lastname: Kambili
mesh_terms: D000995:Antitubercular Agents / Q000627:therapeutic use*; D064687:Diarylquinolines / Q000627:therapeutic use*; D006801:Humans; D018088:Tuberculosis, Multidrug-Resistant / Q000188:drug therapy*
chemical_list: D000995:Antitubercular Agents; D064687:Diarylquinolines; C493870:bedaquiline